Clinical Trial Update: Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of Adalimumab in adult Chinese patients with active Ankylosing Spondylitis, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Abbott | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED | Results posted: 2011-11-04